HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ann Marie Ogden Selected Research

Migraine Disorders (Migraine)

8/2006Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ann Marie Ogden Research Topics

Disease

2Pain (Aches)
10/2006 - 08/2006
1Hyperalgesia
10/2006
1Migraine Disorders (Migraine)
08/2006
1Anxiety Disorders (Anxiety Disorder)
04/2006
1Seizures (Absence Seizure)
04/2006

Drug/Important Bio-Agent (IBA)

2Kainic Acid Receptors (Kainate Receptor)IBA
10/2006 - 04/2006
1CarrageenanIBA
10/2006
1Amino AcidsFDA Link
10/2006
1Capsaicin (Zostrix)FDA Link
10/2006
1Glutamic Acid (Glutamate)FDA Link
08/2006
16- ((2- carboxy- 4,4- difluoro- 1- pyrrolidinyl)methyl)decahydro- 3- isoquinolinecarboxylic acidIBA
08/2006
1Blood Proteins (Serum Proteins)IBA
08/2006
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2006
1Anti-Anxiety Agents (Anxiolytics)IBA
04/2006
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2006
1N-Methylaspartate (NMDA)IBA
04/2006
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
04/2006
1tezampanelIBA
04/2006